Stay informed with the latest updates for the inheritable blood disorders community. Industry Recruitment Reopened for Phase 3 AFFINE Gene Therapy Trial Sep 23, 2022 Press Releases NHF Announces Fall 2022 Wednesday Webinar ScheduleSep 21, 2022 NBDF & Community Meet Former NYLI Member, Patti Williford!Sep 16, 2022 NBDF & Community Meet Former NYLI Member, Joseph Mah!Sep 16, 2022 NBDF & Community Meet Former NYLI Member, Dejah Smith!Sep 16, 2022 NBDF & Community Message from NHF CEO Len ValentinoSep 15, 2022 Medical Update for the Hemophilia CommunitySep 12, 2022 Medical Virtual Grand Round Series to Focus on Hemophilia Gene TherapySep 12, 2022 Industry FDA Grants Priority Review for Sanofi’s BIVV001Sep 6, 2022 Industry Rare Factor X Deficiency Survey Shows Disparity in Care Sep 1, 2022 Press Releases NHF Announces its Awards of Excellence 2022 Winners Aug 28, 2022 Industry BioMarin Receives Conditional Approval in Europe for Gene TherapyAug 25, 2022 Medical PPTA Posts Statement on Monkeypox and Plasma Protein TherapiesAug 22, 2022 Industry BioMarin Presents Abstract on Vector DNA Transmission Risk at ISTHAug 4, 2022 Industry New Prophylaxis Approval for REBINYN®Aug 3, 2022 Pagination First page Previous page … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page Last page